NEWS

WIRES

OTHER

PhyNexus and BAC BV Launch Full Range of CaptureSelect Resins in PhyTip Column Format

The PhyTip columns containing CaptureSelect^® resins are compatible with parallel processing in automated format. The columns can be used with any of a major manufacturer's robotic liquid handler's platforms. Pure and highly concentrated samples obtained from the processing are ready for cell-based assays, analytics or any desired functional test. In addition, PhyTip columns allow researchers to scout for the best purification conditions that result in high yield and activity by setting up a matrix of purification conditions.

"BAC has created a unique and powerful platform for affinity purification with its range of CaptureSelect products," commented Dr. Douglas Gjerde, CEO of PhyNexus, adding: "The availability of the CaptureSelect resins in the PhyTip^® column format provides additional flexibility to scientists who wish to determine the best purification conditions for their needs."

Dr. Laurens Sierkstra, CEO of BAC BV also commented: "By collaborating with PhyNexus, we are delighted to be able to respond to the needs of researchers who are looking for simple and reliable high through-put screening tools to support their antibody research."

PHYNEXUS and PHYTIP are registered trademarks of PhyNexus, Inc.

CAPTURESELECT is a registered trademark of BAC BV.

About PhyNexus

PhyNexus Inc. has developed a unique technology to address the need for high throughput performance for small-volume protein purification with its range of PhyTip columns. These columns allow for rapid and routine parallel purification in a walk-away fashion. The instruments, columns and their use is the subject of several domestic and foreign patents and patent applications. For more information about PhyNexus, visit our website at www.phynexus.com.

About BAC BV

BAC discovers, develops and manufactures affinity ligands and affinity purification products to support biopharmaceutical research and production. BAC's CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. These products enable a reduced time to market, increased purity and yield and an overall lower cost of goods for biopharmaceutical drug development. BAC BV was established in 1995 as a Unilever subsidiary. Currently the Company employs 37 people with an R&D laboratory facility in Leiden and a state-of-the-art ISO 9001 certified manufacturing plant in Naarden, the Netherlands. For more information about BAC, visit our website at www.bacbv.com. For more information about CaptureSelect products, visit our website at www.captureselect.com.

For PhyNexus, Inc.:
Tiffany Nguyen, 408-267-7214
info@phynexus.com
or
For BAC BV:
College Hill Life Sciences
Dr Lynne Trowbridge or Dr Anastasios Koutsos, +44 20-7457-2020
BAC@collegehill.com